The global diabetes market is experiencing a surge driven by the increasing prevalence of this chronic disease. At the forefront of this evolution are leading companies of GLP-1 receptor agonists, a class of drugs that https://e-bookmarks.com/story6037315/leading-glp-1-manufacturers-innovation-in-diabetes-treatment